BRIEF-Phathom Pharmaceuticals Submits Citizen Petition To FDA Dec 11 (Reuters) - Phathom Pharmaceuticals PHAT.O:
PHATHOM PHARMACEUTICALS SUBMITS CITIZEN PETITION TO FDA SEEKING CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA® (VONOPRAZAN) TABLETS
PHATHOM: PETITION REQUESTS CORRECTION OF ORANGE BOOK LISTINGS FOR VOQUEZNA 10 MG,20 MG TABLETS TO ACCURATELY REFLECT 10-YEAR NCE EXCLUSIVITY PERIOD
PHATHOM PHARMACEUTICALS INC: EXCLUSIVITY PERIOD IS UNTIL MAY 3, 2032
Source text: ID:nGNXMt0NF
Further company coverage: PHAT.O
((Reuters.Briefs@thomsonreuters.com;))
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments